EP
DXCM icon

Essential Partners’s DexCom DXCM Stock Holding History

Essential Partners’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$50.2K Sell
745
-1,072
-59% -$71.4K 0.02% 617
2026
Q1 		$114K Sell
1,817
-320
-15% -$22.3K 0.04% 392
2025
Q4 		$142K Sell
2,137
-1,423
-40% -$92K 0.04% 377
2025
Q3 		$240K Buy
3,560
+135
+4% +$10.7K 0.08% 291
2025
Q2 		$299K Buy
+3,425
New +$268K 0.12% 230

Other funds holding DXCM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Essential Partners's DXCM Position: Q2 2026 in Review

Essential Partners reduced its DexCom (DXCM) stake by 59% in Q2 2026, selling an estimated $71.4K and leaving 745 shares worth $50.2K. The position accounts for 0.02% of the portfolio, ranked #617.

Essential Partners first reported a position in DXCM in Q2 2025 and has held it in 5 quarters since. The position peaked at $299K in Q2 2025. 971 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Essential Partners held 745 shares of DexCom worth $50.2K as of Q2 2026.
  • Essential Partners sold 1,072 DexCom shares in Q2 2026, an estimated $71.4K.
  • DexCom made up 0.02% of Essential Partners's portfolio in Q2 2026, its #617 holding.
  • Essential Partners first reported a position in DexCom in Q2 2025 and has held it in 5 quarters since.
  • Essential Partners's DexCom position peaked at $299K in Q2 2025.
  • 971 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Essential Partners's 13F filing for Q2 2026, filed 10 Aug 2026.